| ATNF Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ATNF market cap history going back to 8/19/2020:
Also see: ATNF Shares Outstanding History and ATNF YTD Return |
As of 7/22/2025 180 Life Sciences has a market cap of 13.35 million. Investors often follow the ATNF market cap history to compare the size of the company over time.
This page shows ATNF market capitalization trends over time, with 21 market cap datapoints presented, dating back to 8/19/2020.

| ATNF Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ATNF market cap history going back to 8/19/2020:
Also see: ATNF Shares Outstanding History and ATNF YTD Return |
| ATNF Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||
ATNF Historical Market Cap: -26.31% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||
| ATNF Stock Price Chart |
| About ETHZilla Corp |
| 180 Life Sciences Corp. is a clinical-stage biotechnology company focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis. Co. is primary focused on program to treat several inflammatory disorders using anti-TNF (tumor necrosis factor). Co. has three product development platforms: Anti-TNF platform, SCAs platform and a7nAChR platform. Anti-TNF platform is focused on fibrosis and anti-tumor necrosis factor (anti-TNF). SCAs platform is focused on drugs which are synthetic cannabidiol (CBD) or cannabigerol (CBG) analogues (SCAs). a7nAChR platform is focused on alpha 7 nicotinic acetylcholine receptor (a7nAChR). We show 21 historical shares outstanding datapoints in our ATNF shares outstanding history coverage, used to compute ATNF market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ATNF market cap history over the course of time is important for investors interested in comparing ATNF's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ATNF versus a peer is one thing; comparing ATNF market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ATNF can fluctuate over the course of history. With this page we aim to empower investors researching ATNF by allowing them to research the ATNF market cap history. |
| ATNF Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: The Importance of Market Cap | |
|
| ATNF Share Performance |
| Market Cap Peers |
| 180 Life Sciences (ATNF) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
ATNX Market Cap History ATOS Market Cap History ATRA Market Cap History ATRC Market Cap History ATRI Market Cap History ATRS Market Cap History ATXI Market Cap History ATXS Market Cap History ATYR Market Cap History AURA Market Cap History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.